MedTrace Logo

Function of Beta Cells in Early-onset Diabetes Mellitus

NCT07574138 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 296

Last updated 2026-05-07

No results posted yet for this study

Summary

* Research objectives: Evaluate and compare the clinical and paraclinical characteristics, complications, as well as the changes in beta cell function and HbA1C levels between two patient groups over a one-year follow-up period.

+Research design: This is a prospective cohort study, monitoring patients at 3, 6, 9, and 12 months.
* Study Population and Sample Size: The study is planned to be conducted on 296 Vietnamese patients (accounting for a 20% dropout rate) who are being examined at the University of Medicine and Pharmacy Hospital in Ho Chi Minh City.
* Key Evaluation Indicators: The function of beta cells and insulin resistance status are measured through the indices of HOMA-B, HOMA-IR, fasting C-peptide levels, and HbA1C levels.
* Time and location: The study will be conducted from February 2025 to February 2028 at the Endocrinology Clinic, University Medical Center Ho Chi Minh City.

Conditions

  • Type 2 Diabetes Mellitus (T2DM)
  • Beta Cell Function

Interventions

OTHER

Monitor and observe the clinical progression and beta cell function

Monitor and observe the clinical progression and beta cell function

Sponsors & Collaborators

  • University Medical Center Ho Chi Minh City (UMC)

    lead OTHER

Principal Investigators

  • Chi Khanh Hoang, Specialist physician level 1 · University of Medicine and Pharmacy of Ho Chi Minh City

  • Nam Quang Tran, Associate professor - Doctorat · University of Medicine and Pharmacy of Ho Chi Minh City

  • Tran Viet Thang, Doctorate · University of Medicine and Pharmacy of Ho Chi Minh City

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-24
Primary Completion
2027-12-31
Completion
2028-02-29

Countries

  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07574138 on ClinicalTrials.gov